Investing.com - Novo Nordisk (CSE:NOVOb) ADR reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr0.8373 on revenue of kr5.26B. Analysts polled by Investing.com anticipated EPS of kr0.7753 on revenue of kr5.15B.
Novo Nordisk ADR shares are down 14.42% from the beginning of the year and are trading at kr101.23 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by J&J on July 21, who reported EPS of kr2.48 on revenue of kr23.31B, compared to forecasts EPS of kr2.29 on revenue of kr22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of kr4.7 on revenue of kr71.32B, compared to forecast for EPS of kr4.43 on revenue of kr69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar